Literature DB >> 3338703

Hepatofugal portal flow in cirrhosis: observations on hepatic hemodynamics and the nature of the arterioportal communications.

W G Rector1, J C Hoefs, K F Hossack, G T Everson.   

Abstract

Six of 85 patients (7%) with alcoholic liver disease undergoing transhepatic portal pressure measurement had either stagnant (3 patients) or reversed (3 patients) portal blood flow documented by gentle hand injection of 1 to 2 ml of angiographic contrast. Portal blood flow was uniformly hepatopetal in 24 patients with nonalcoholic liver disease. Recurrent spontaneous hepatic encephalopathy and sodium retention occurred in 4 of 6 patients with stagnant or reversed portal flow; gastrointestinal bleeding was not seen. Standard laboratory tests of liver function were widely variable. Net portal pressure was lower in this group than in patients with alcoholic liver disease and forward portal flow (9.2 +/- 2.6 vs. 15.6 +/- 4.1 mm Hg, p less than 0.001). Wedged hepatic vein pressure was 1 to 7 mm Hg higher than portal vein pressure in patients with reversed portal flow. The arterioportal extraction of bile acid was calculated from the difference in concentration between artery and portal vein, and total functional hepatic blood flow was calculated from the hepatic extraction and systemic clearance of indocyanine green. Extraction was 0%, and hepatic blood flow was 0.469 liter per min in a patient with hepatofugal portal flow and recurrent encephalopathy. Extraction was 20%, and hepatic blood flow was 4.014 liters per min in a patient who had never had encephalopathy. These data indicate that arterioportal communications may be sinusoidal or presinusoidal in patients who lose forward portal flow and that the amount of flow in the arterioportal circuit, together with its efficiency, largely determine the clinical outcome.

Entities:  

Mesh:

Year:  1988        PMID: 3338703     DOI: 10.1002/hep.1840080105

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Non-invasive diagnosis of portal vein occlusion by radionuclide angiography.

Authors:  P MacMathuna; M K O'Connor; D G Weir; P W Keeling
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

2.  Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.

Authors:  F Albani; M R Tamè; R De Palma; M Bernardi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Nodular regenerative hyperplasia mimicking cirrhosis of the liver.

Authors:  J A McDonald; D M Painter; N D Gallagher; G W McCaughan
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

4.  Transient hepatofugal portal blood flow after hepatectomy in a patient with cirrhosis: report of a case.

Authors:  M Kajikawa; A Harada; H Kobayashi; Y Kasai; T Nonami; A Nakao; H Takagi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Pharmacokinetics, hepatic biotransformation and biliary and urinary excretion of bromosulfophthalein (BSP) in an experimental liver disease mimicking biliary cirrhosis.

Authors:  A Esteller; M D Torres; M Gomez-Bautista; E L Mariño; C Fernandez-Lastra; R Jimenez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

6.  Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.

Authors:  Roland H Stimson; Jonas Andersson; Ruth Andrew; Doris N Redhead; Fredrik Karpe; Peter C Hayes; Tommy Olsson; Brian R Walker
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

7.  Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis.

Authors:  Sebastian Mueller
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.